Holen Sie sich die Stockscreener-App
165.51
0.52%
-0.72
Handel nachbörslich:
165.43
-0.08
-0.05%
Schlusskurs vom Vortag:
$166.23
Offen:
$167.72
24-Stunden-Volumen:
1.86M
Relative Volume:
1.04
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.31%
1M Leistung:
-4.13%
6M Leistung:
+17.30%
1J Leistung:
+24.21%
1-Tages-Spanne:
$164.78
$169.00
1-Wochen-Bereich:
$164.78
$174.06
52-Wochen-Spanne:
$107.43
$179.64
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
165.51 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
662.36 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
665.29 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.72 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps - Benzinga
SOXXBlackRock Announces Product Updates to Two iShares ETFs - mx.advfn.com
Aster Capital Management DIFC Ltd Makes New Investment in iShares Biotechnology ETF $IBB - Defense World
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
7 Best Healthcare ETFs for Long-Term Investors - Coinpaper
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Merit Financial Group LLC Trims Stock Holdings in iShares Biotechnology ETF $IBB - Defense World
Caprock Group LLC Takes Position in iShares Biotechnology ETF $IBB - Defense World
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026? - TipRanks
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Reasons the Biotech Sector Might Be Shifting and the Implications of the iShares Biotechnology ETF (IBB) - Intellectia AI
Biotech in Flux: Patent Cliff and IPO Revival Shape the IBB - AD HOC NEWS
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
Biotech ETF Recommended, Amcor Reports Strong Earnings - Intellectia AI
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Amcor, Emerson Electric And More: CNBC's 'Final Trades' - Benzinga
Biotechnology Sector Faces Headwinds as Key ETF Navigates Challenges - AD HOC NEWS
6 Best Health Care Funds and ETFs to Buy Now - US News Money
Florin Court Capital LLP Makes New Investment in iShares Biotechnology ETF $IBB - Defense World
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF - AOL.com
IBB: Beyond The 2025 Surge, Biotech Breakout (NASDAQ:IBB) - Seeking Alpha
IBB: Biotech's Hot Streak May Cool (NASDAQ:IBB) - Seeking Alpha
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 - The Motley Fool
Health Care Stocks Steady, iShares Biotechnology ETF Inactive - Intellectia AI
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground - Benzinga
SG Americas Securities LLC Has $4.13 Million Stock Position in iShares Biotechnology ETF $IBB - Defense World
A Tale of Two Biotechs: Stability and Speculation in the ETF Arena - AD HOC NEWS
D.A. Davidson & CO. Increases Stock Position in iShares Biotechnology ETF $IBB - Defense World
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Head-To-Head Survey: iShares Biotechnology ETF (NASDAQ:IBB) vs. Nuveen New York Municipal Valu (NYSE:NNY) - Defense World
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Bigelow Investment Advisors LLC Has $505,000 Holdings in iShares Biotechnology ETF $IBB - Defense World
Price to earnings ratio of iShares Biotechnology ETF Shs Cert Deposito Arg Repr 0.037037037 Sh – BCBA:IBBD - TradingView — Track All Markets
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84% - Intellectia AI
2 Brilliant Biotech ETFs to Watch in 2026 - AOL.com
Analyst IMS Investment Management Services Ltd. Trims Stock Position in iShares Biotechnology ETF $IBB - Defense World
Head-To-Head Survey: Saba Capital Income & Opportunities Fund II (NYSE:SABA) and iShares Biotechnology ETF (NASDAQ:IBB) - Defense World
Is iShares Biotechnology ETF (IBB) a strong ETF right now? - MSN
Why This Fund Cashed Out of a $3.6 Million Biotech ETF Bet - AOL.com
Daily ETF Flows: Biotech ETF "IBB" Makes The Cut - Yahoo Finance
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026 - Benzinga
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):